Parkinson's disease in Arabs: A systematic review

Studies of specific populations have provided invaluable knowledge about Parkinson's disease (PD), especially in the field of genetics. The present report systematically reviews the medical literature on PD in Arabs. Medline and Embase were searched, and 24 article were identified: genetic (n = 17), epidemiological (n = 3), and clinical series (n = 5). Both autosomal dominant and recessive forms of inherited PD are described, associated with four genes (Parkin, PINK1, LRRK2, and PARK9). The G2019S LRRK2 mutation is more common in both familial (37–42%) and apparently sporadic PD (41%) in North African Arabs than in Europeans and North Americans (2–3%). The incidence of PD is reported at 4.5 per 100,000 person‐years and reported prevalence at 27 to 43 per 100,000 persons. Hospital‐based clinical series suggest that parkinsonism is the commonest movement disorder. Clinical features of PD in Arabs are not significantly different from those reported elsewhere. PD was reported as the cause of dementia in around 7% of Arabs. The majority of studies relate to the role of genes in the etiology of PD in North African Arabs. Further genetic, epidemiological and clinical studies from the majority of Arabic countries may enhance our understanding of PD. © 2008 Movement Disorder Society.

[1]  P. Pollak,et al.  LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. , 2006, The New England journal of medicine.

[2]  A. Jon Stoessl,et al.  Etiology of Parkinson's Disease , 2003, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[3]  Y. Agid,et al.  Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism , 1998, The Lancet.

[4]  Jan Gründemann,et al.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.

[5]  O. Elwan,et al.  Parkinson's disease, cognition and aging Clinical, neuropsychological, electrophysiological and cranial computerized tomographic assessment , 1996, Journal of the Neurological Sciences.

[6]  K. Marder,et al.  The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. , 1995, American journal of epidemiology.

[7]  Dementia in Qatar. , 2004, Saudi medical journal.

[8]  N. Hattori,et al.  Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological study. , 2003, Parkinsonism & related disorders.

[9]  A. Mubaidin,et al.  Pallido‐pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor‐Rakeb syndrome , 1994, Acta neurologica Scandinavica.

[10]  J. Meara,et al.  Parkinson's disease epidemiology in the Northampton District, England, 1992 , 1995, Acta neurologica Scandinavica.

[11]  M. Carreras,et al.  Parkinson's disease in Ferrara, Italy, 1967 through 1987. , 1991, Archives of neurology.

[12]  Josemir W Sander,et al.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. , 2000, Brain : a journal of neurology.

[13]  S. Roy,et al.  Parkinson's disease in a Scottish city. , 1986, British medical journal.

[14]  Houeto Jean-Luc [Parkinson's disease]. , 2022, La Revue du praticien.

[15]  Y. Agid,et al.  G2019S LRRK2 mutation in French and North African families with Parkinson's disease , 2005, Annals of neurology.

[16]  L. Forsgren,et al.  Community-based study of neurological disorders in rural central Ethiopia. , 1990, Neuroepidemiology.

[17]  E. Granieri,et al.  The risk of Parkinson disease in Mediterranean people , 1980, Neurology.

[18]  Stéphane Thobois,et al.  Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. , 2006, Brain : a journal of neurology.

[19]  M. Hamida,et al.  Prevalence study of neurologic disorders in Kelibia (Tunisia). , 1993, Neuroepidemiology.

[20]  S. Galal The Arab World , 1975, Nature.

[21]  A. Ogunniyi,et al.  Dementia in Saudi Arabia: experience from a university hospital , 1998, Acta neurologica Scandinavica.

[22]  T. Foroud,et al.  Mutations in LRRK2 other than G2019S are rare in a north american–based sample of familial Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[23]  J. Nutt,et al.  LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. , 2006, American journal of human genetics.

[24]  A. Awada,et al.  A community survey of neurological disorders in Saudi Arabia: the Thugbah study. , 1993, Neuroepidemiology.

[25]  M. Hamida,et al.  Clinical and genetic study of familial Parkinson’s disease in Tunisia , 2000, Neurology.

[26]  J. Jankovic,et al.  A founding LRRK2 haplotype shared by Tunisian, US, European and Middle Eastern families with Parkinson's disease. , 2008, Parkinsonism & related disorders.

[27]  B. Osuntokun,et al.  Neurological disorders in Nigerian Africans: a community‐based study , 1987, Acta neurologica Scandinavica.

[28]  K. Takahashi,et al.  Epidemiology of Parkinson's disease in a Japanese city. , 1983, Archives of neurology.

[29]  D. Maraganore,et al.  Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies , 2006, Movement disorders : official journal of the Movement Disorder Society.

[30]  J. Jankovic,et al.  Screening for Lrrk2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families , 2007, Movement disorders : official journal of the Movement Disorder Society.

[31]  O. Axelson,et al.  Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community. , 1996, Journal of clinical epidemiology.

[32]  B. Funalot,et al.  Genetic screening for two LRRK2 mutations in French patients with idiopathic Parkinson's disease. , 2006, Genetic testing.

[33]  K. Nakashima,et al.  Epidemiology of Parkinson's disease in Yonago City, Japan: comparison with a study carried out 12 years ago. , 1996, Neuroepidemiology.

[34]  M. Farrer,et al.  Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. , 2006, Archives of neurology.

[35]  A. Lees,et al.  Kufor Rakeb Disease: Autosomal recessive, levodopa‐responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia , 2005, Movement disorders : official journal of the Movement Disorder Society.

[36]  A. Dürr,et al.  Juvenile-onset Parkinsonism as a result of the first mutation in the adenosine triphosphate orientation domain of PINK1. , 2006, Archives of neurology.

[37]  P. S. St George-Hyslop,et al.  T313M PINK1 mutation in an extended highly consanguineous Saudi family with early-onset Parkinson disease. , 2006, Archives of neurology.

[38]  U. Rinne,et al.  EPIDEMIOLOGY of PARKINSON'S DISEASE IN FINLAND , 1976, Acta neurologica Scandinavica.

[39]  Parkinson's disease. Clinical and electrophysiological evaluation. , 2000, Saudi medical journal.

[40]  A. Dürr,et al.  LRRK2 haplotype analyses in European and North African families with Parkinson disease: a common founder for the G2019S mutation dating from the 13th century. , 2005, American journal of human genetics.

[41]  B. Jeune,et al.  A two‐fold difference in the age‐adjusted prevalences of Parkinson’s disease between the island of Als and the Faroe Islands , 2000, European journal of neurology.

[42]  Christine Klein,et al.  LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. , 2006, The New England journal of medicine.

[43]  J. Ghika [Genetics of parkinsonism]. , 2000, Revue medicale de la Suisse romande.

[44]  C. Woods,et al.  Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36 , 2001, Journal of medical genetics.

[45]  K. Radhakrishnan,et al.  Epidemiology of Parkinson's disease in Benghazi, North-East Libya , 1986, Clinical Neurology and Neurosurgery.

[46]  D. Weeks,et al.  Autosomal recessive juvenile parkinsonism maps to 6q25.2-q27 in four ethnic groups: detailed genetic mapping of the linked region. , 1998, American journal of human genetics.